{"disease":{"id":"epidermal-growth-factor-receptor-egfr-mutated-non-small-cell-lung-cancer","name":"epidermal growth factor receptor egfr mutated non small cell lung cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06099639","title":"Medical Access Program for Patritumab Deruxtecan","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Daiichi Sankyo","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}